ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.72901
-0.02%
Brent Oil
81.185
-0.15%
Bitcoin
67,779.27
-0.22%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
23/05/202421:00GlobeNewswire Inc.Fairfax Announces the Passing of Ramaswamy AthappanTSX:FFH.UFairfax Financial Holdings Limited
23/05/202420:55PR Newswire (US)Azul and GOL Announce Codeshare AgreementNYSE:AZULAzul SA
23/05/202420:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
23/05/202420:52PR Newswire (Canada)Rappel du gobelet NÜTRL de la marque Sunscope au Canada
23/05/202420:50Business Wireセルトリオン、欧州委員会からオマリズマブ バイオシミラー「Omlyclo®（CT-P39）」の承認を取得 – 欧州初・唯一の承認
23/05/202420:49GlobeNewswire Inc.Imperial Announces Voting Results for the Election of DirectorsTSX:IIIImperial Metals Corporation
23/05/202420:49Business WireCelltrion riceve l'approvazione della Commissione europea per Omlyclo® (CT-P39), il primo e unico farmaco biosimilare di omalizumab approvato in Europa
23/05/202420:48PR Newswire (US)LENNAR DFW DIVISION HOSTS HOPEKIDS EVENT FOR CHILDREN WITH LIFE-THREATENING MEDICAL CONDITIONS AT KIDZANIA USA
23/05/202420:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
23/05/202420:44PR Newswire (Canada)Sunscope Recalls NÜTRL-Branded Tumbler Cup in Canada
23/05/202420:43PR Newswire (US)What made ASML so successful today: DIGITIMES Asia's Q&A with Dutch Journalist and author Marc Hijink
23/05/202420:42Business WireThe World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
23/05/202420:37GlobeNewswire Inc.Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
23/05/202420:31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INSEInspired Entertainment Inc
23/05/202420:31PR Newswire (US)IEHP's newly announced Community Wellness Center adds more heart to the city of San Bernardino
23/05/202420:26Business WireCelltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
23/05/202420:23NEWSBTCBitcoin Price Dips Again: Market Fluctuation or Start of a Correction?COIN:BTCUSDBitcoin
23/05/202420:21PR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc
23/05/202420:20PR Newswire (Canada)TSX Venture Exchange Stock Maintenance Bulletins
23/05/202420:19GlobeNewswire Inc.ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des JahresEU:ONWDOnward Medical NV
23/05/202420:19GlobeNewswire Inc.ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écouléeEU:ONWDOnward Medical NV
23/05/202420:15PR Newswire (US)ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
23/05/202420:03GlobeNewswire Inc.Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024NASDAQ:ANLAdlai Nortye Ltd
23/05/202420:02PR Newswire (US)Heart to Heart Hospice of San Antonio Opens New Hospice House
23/05/202420:00Crypto BriefingBlackRock’s Ethereum spot ETF listed on DTCC under ticker $ETHACOIN:ETHUSDEthereum
23/05/202419:53Business WireThe 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jackson, Charlie Wilson, Victoria Monét...
23/05/202419:47PR Newswire (Canada)Consilio conclut un accord stratégique pluriannuel avec Nuix
23/05/202419:41PR Newswire (Canada)Plus de 1 700 participant.e.s réunis au Forum innovation aérospatiale international d'Aéro Montréal
23/05/202419:39Business WireLee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of Lakes
23/05/202419:35PR Newswire (Canada)More than 1,700 participants attend Aéro Montréal's International Aerospace Innovation Forum

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
CCOM
US500
US 500
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados